These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 83826)

  • 21. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
    Hollister AS; Breese GR; Mueller RA
    J Pharmacol Exp Ther; 1979 Jan; 208(1):37-43. PubMed ID: 759613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.
    Lacombe E; Carcenac C; Boulet S; Feuerstein C; Bertrand A; Poupard A; Savasta M
    Eur J Neurosci; 2007 Sep; 26(6):1670-80. PubMed ID: 17822436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The hypothermic effect of L-dopa in the rat.
    Maj J; Pawlowksi L
    Life Sci; 1973 Jul; 13(2):141-9. PubMed ID: 4270866
    [No Abstract]   [Full Text] [Related]  

  • 24. Biochemical changes in tissue catecholamines and serotonin in duodenal ulceration caused by cysteamine or propionitrile in the rat.
    Szabo S; Horner HC; Maull H; Schnoor J; Chiueh CC; Palkovits M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):871-8. PubMed ID: 3559978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. gamma-Glutamyl DOPA and gamma-glutamyl dopamine: effect on plasma glucose levels.
    Mizoguchi H; Orlowski M; Wilk S; Green JP
    Eur J Pharmacol; 1979 Aug; 57(2-3):239-45. PubMed ID: 488163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anorexigenic effects of d-amphetamine and l-DOPA in the rat.
    Sanghvi IS; Singer G; Friedman E; Gershon S
    Pharmacol Biochem Behav; 1975; 3(1):81-6. PubMed ID: 1129359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia.
    García J; Carlsson T; Döbrössy M; Nikkhah G; Winkler C
    Neurobiol Dis; 2011 Sep; 43(3):576-87. PubMed ID: 21600983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible role of serotonin in the monoamines-induced inhibition of the stress mechanism in the rat.
    Vermes I; Dull G; Telegdy G; Lissák K
    Acta Physiol Acad Sci Hung; 1972; 42(3):219-23. PubMed ID: 4270564
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease.
    Navailles S; Bioulac B; Gross C; De Deurwaerdère P
    Neurobiol Dis; 2011 Feb; 41(2):585-90. PubMed ID: 21092759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of drugs interfering with biogenic amine metabolism on basal gastric secretion in the rat.
    Hano J; Bugajski J; Danek L
    Pol J Pharmacol Pharm; 1973; 25(6):537-49. PubMed ID: 4151861
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of tetrahydropapaveroline on dopamine and 5-hydroxytryptamine metabolism in rat brain in vivo.
    Livrea P; Di Reda L; Giovine A; Bertolino A
    Pharmacology; 1976; 14(1):20-6. PubMed ID: 134381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cyclic changes in the excitability of the cerebral cortex in alert rats under conditions of direct interference with serotonin and noradrenaline metabolism].
    Gromova EA; Vorob'ev VV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1977; 27(6):1193-7. PubMed ID: 145764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of d-amphetamine and disruption of 5-hydroxytryptaminergic neuronal systems on the synthesis of dopamine in selected regions of the rat brain.
    Lyness WH; Demarest KT; Moore KE
    Neuropharmacology; 1980 Sep; 19(9):883-9. PubMed ID: 6448358
    [No Abstract]   [Full Text] [Related]  

  • 34. 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
    Huang X; Nichols DE
    Eur J Pharmacol; 1993 Jul; 238(2-3):291-6. PubMed ID: 8104811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of long-term L-dopa administration on brain biogenic amines and behavior in the rat.
    Narotzky R; Griffith D; Stahl S; Bondareff W; Zeller EA
    Exp Neurol; 1973 Feb; 38(2):218-30. PubMed ID: 4690179
    [No Abstract]   [Full Text] [Related]  

  • 36. Serotonin synthesis with rat brain synaptosomes. Effects of L-dopa, L-3-methoxytyrosine and catecholamines.
    Karobath M; Diaz JL; Huttunen M
    Biochem Pharmacol; 1972 May; 21(9):1245-51. PubMed ID: 5038670
    [No Abstract]   [Full Text] [Related]  

  • 37. [Participation of the serotoninergic system of the brain in regulation of emotional reactivity].
    Allikmets LKh; Zharkovskiĭ AM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1975; 25(6):1284-91. PubMed ID: 128934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-DOPA: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.
    Everett GM; Borcherding JW
    Science; 1970 May; 168(3933):847-50. PubMed ID: 5444060
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum.
    Kaakkola S; Wurtman RJ
    J Neurochem; 1993 Jan; 60(1):137-44. PubMed ID: 8417137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone.
    Nissinen E; Lindén IB; Schultz E; Pohto P
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):262-6. PubMed ID: 1407012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.